News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boston Scientific Corporation (BSX) To Collaborate With Affinergy, Inc. On Novel Cardiovascular Stent Coatings



11/1/2005 3:04:42 PM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov. 1, 2005--Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, recently signed a collaboration agreement with Boston Scientific (NYSE: BSX) to investigate new coatings for cardiovascular stents. Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a broad range of interventional medical specialties.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES